Sep 10, 2024 - Update Shaping the future of dementia research: Meet the UK DRI’s newest Emerging Leaders We are pleased to announce three new UK DRI Emerging Leaders: Dr Maura Malpetti, Dr... Learn more Shaping the future of dementia research: Meet the UK DRI’s newest Emerging Leaders
Jan 01, 2024 - Feature Why partner with the UK DRI? The UK DRI is central to a rich and connected dementia research ecosystem, and we... Learn more Why partner with the UK DRI?
Jan 01, 2024 - Feature Why join the UK DRI? By joining the UK DRI you’ll belong to a team of world-class researchers, technical specialists... Learn more Why join the UK DRI?
Search for keywords Condition ConditionAlzheimer's diseaseFrontotemporal dementiaHuntington's diseaseLewy body dementiaMild cognitive impairmentMotor neuron disease/ALSOther dementiasParkinson's diseaseVascular dementia Techniques TechniquesAdvanced microscopy & imagingAdvanced spectroscopyBioinformaticsBiophysical techniquesCRISPRDrug screeningElectrophysiologyEpigenomicsExperimental medicineFlow cytometryFluid biomarkersGenomicsHuman brain imagingLipidomicsMass spec-based proteomicsMetabolomicsMouse behaviourMouse in vivo imagingNext generation sequencingNon-mammalian animal modelsOptogeneticsRobotics & environmental sensingSingle cell / nucleus transcriptomicsSoftware developmentSpatial transcriptomicsStatistical modellingStem cells / iPSCsStructural biologyTranscranial brain stimulationViral-mediated expression Topic TopicAgeingBiomarkers & diagnosticsCare & Home technologyCell biology of neurons & gliaGeneticsImmune systemLifestyle & environmentMolecular mechanismsSleep & Circadian rhythmsSynapse & CircuitryTreatments & InterventionsVascular system Dr Emma Clayton Emerging Leader UK DRI at King's Investigating presynaptic proteostasis using novel tools in novel models Learn more Dr Emma Clayton Dr Sarah Marzi Group Leader UK DRI at King's Investigating how epigenetics regulates biological mechanisms in health and disease Learn more Dr Sarah Marzi Dr Sarah Mizielinska Group Leader UK DRI at King's Understanding the precise mechanisms of nucleocytoplasmic dysfunction in FTD and ALS Learn more Dr Sarah Mizielinska Dr Marc-David Ruepp Group Leader UK DRI at King's Exploring RNA metabolism in health and neurodegeneration Learn more Dr Marc-David Ruepp Dr Andrea Serio Group Leader UK DRI at King's Combining bioengineering, imaging, and stem cell modelling to better understand motor neuron disease and dementia Learn more Dr Andrea Serio Prof Chris Shaw Group Leader UK DRI at King's Pioneering gene therapies to treat amyotrophic lateral sclerosis and frontotemporal dementia Learn more Prof Chris Shaw Prof Jernej Ule Centre Director UK DRI at King's Deciphering the role of RNA in amyotrophic lateral sclerosis and frontotemporal dementia Learn more Prof Jernej Ule
Dr Emma Clayton Emerging Leader UK DRI at King's Investigating presynaptic proteostasis using novel tools in novel models Learn more Dr Emma Clayton
Dr Sarah Marzi Group Leader UK DRI at King's Investigating how epigenetics regulates biological mechanisms in health and disease Learn more Dr Sarah Marzi
Dr Sarah Mizielinska Group Leader UK DRI at King's Understanding the precise mechanisms of nucleocytoplasmic dysfunction in FTD and ALS Learn more Dr Sarah Mizielinska
Dr Marc-David Ruepp Group Leader UK DRI at King's Exploring RNA metabolism in health and neurodegeneration Learn more Dr Marc-David Ruepp
Dr Andrea Serio Group Leader UK DRI at King's Combining bioengineering, imaging, and stem cell modelling to better understand motor neuron disease and dementia Learn more Dr Andrea Serio
Prof Chris Shaw Group Leader UK DRI at King's Pioneering gene therapies to treat amyotrophic lateral sclerosis and frontotemporal dementia Learn more Prof Chris Shaw
Prof Jernej Ule Centre Director UK DRI at King's Deciphering the role of RNA in amyotrophic lateral sclerosis and frontotemporal dementia Learn more Prof Jernej Ule
